Edition:
United States

People: Pfizer Inc (PFE)

PFE on New York Consolidated

32.14USD
26 May 2017
Change (% chg)

$-0.02 (-0.06%)
Prev Close
$32.16
Open
$32.18
Day's High
$32.29
Day's Low
$32.10
Volume
11,699,041
Avg. Vol
23,676,060
52-wk High
$37.39
52-wk Low
$29.83

D'Amelio, Frank 

Mr. Frank A. D'Amelio is Chief Financial Officer, Executive Vice President - Business Operations of the Company. He was Senior Vice President and Chief Financial Officer from September 2007 until December 2010. Prior to joining Pfizer, he was Senior Executive Vice President of Integration and Chief Administrative Officer of Alcatel-Lucent from November 2006 until August 2007. Prior to the Alcatel-Lucent merger, he was Chief Operating Officer of Lucent and before that Chief Financial Officer of Lucent. Director of Zoetis Inc. and of Humana Inc. and Chair of the Humana Audit Committee. He is a Director of the Independent College Fund of New Jersey.

Basic Compensation

Total Annual Compensation, USD 3,064,000
Restricted Stock Awards, USD 1,144,490
Long-Term Incentive Plans, USD --
All Other, USD 3,485,860
Fiscal Year Total, USD 7,694,350

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ian Read

17,321,500

Frank D'Amelio

7,694,350

Albert Bourla

8,870,440

Mikael Dolsten

8,227,970

John Young

7,395,740

Rady Johnson

--
As Of  30 Dec 2016